Price movement over the last 24 hours
Abbott Laboratories vs VanEck Video Gaming and eSports ETF — how do they compare? Abbott Laboratories trades at $95.38 (market cap $166.94B), while VanEck Video Gaming and eSports ETF trades at $92.17. The key difference: Abbott Laboratories pays a 2.63% dividend while VanEck Video Gaming and eSports ETF pays none. Which is the better fit depends on your goals.
| ABT | ESPO | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Sector/Thematic |
52-Week High | $136.62 | $122.30 |
52-Week Low | $82.57 | $85.25 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
ESPO (VanEck Video Gaming and eSports ETF) trades at $92.89, up 1.04% with bullish technical signals from moving averages. The ETF benefits from AI-driven gaming industry growth potential, with institutional interest shown by Assetmark's 35.9% position increase. Technical indicators show strong trend momentum despite overbought short-term RSI conditions.
The gaming ETF presents exposure to digital entertainment's structural growth, with AI potentially unlocking $22B in industry profits. Key risks include thematic ETF volatility and gaming sector competition. Support at $91-$92 levels provides near-term technical foundation for the current bullish trend.
Trailing returns across standard periods
Latest headlines on both assets
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →